Hepatorenal Syndrome

A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center

Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome

Initial Resuscitation for Acute Kidney Injury in Cirrhosis

Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome

Interest of the Echocardiography in the Management of Cirrhotic Patients With Acute Kidney Injury

Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I

NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients

Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients

HRS-AKI Treatment With TIPS in Patients With Cirrhosis

Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)

Angiotensin 2 for Hepatorenal Syndrome

International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project

A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury

Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome

Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury

Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.

Study To Confirm Efficacy and Safety of Terlipressin in Hepatorenal Syndrome (HRS) Type 1

A Placebo-Controlled, Double-Blind Study to Confirm the Reversal of Hepatorenal Syndrome Type 1 With Terlipressin

MRI to Assess the Effect of Terlipressin in Patients With Acute Hepatorenal Syndrome (HRS-AKI)